Improvement of Mycobacterium abscessus Pulmonary Disease after Nivolumab Administration in a Patient with Advanced Non-small Cell Lung Cancer

Nivolumab has become the standard second-line chemotherapy for non-small cell lung cancer. A 73-year-old man with stage IV non-small cell lung cancer received 6 cycles of chemotherapy with nab-paclitaxel/carboplatin/bevacizumab followed by 11 cycles of nab-paclitaxel/bevacizumab; however, treatment...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Intern Med
Main Authors: Ishii, Seigo, Tamiya, Akihiro, Taniguchi, Yoshihiko, Tanaka, Tsunehiro, Abe, Yuko, Isa, Shun-ichi, Tsuyuguchi, Kazunari, Suzuki, Katsuhiro, Atagi, Shinji
Formato: Artigo
Idioma:Inglês
Publicado: The Japanese Society of Internal Medicine 2018
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6355398/
https://ncbi.nlm.nih.gov/pubmed/30101929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.1195-18
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares